Prevalence and risk factors for hepatitis C virus infection at an urban Veterans Administration Medical Center

被引:88
作者
Briggs, ME
Baker, C
Hall, R
Gaziano, JM
Gagnon, D
Bzowej, N
Wright, TL
机构
[1] Vet Adm Med Ctr, Gastroenterol Sect 111B, Med Serv, San Francisco, CA 94121 USA
[2] W Roxbury VAMC, MAVERIC, San Francisco, CA USA
[3] Univ Calif San Francisco, Dept Med, San Francisco, CA USA
[4] Harvard Univ, Boston, MA 02115 USA
关键词
D O I
10.1053/jhep.2001.29303
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
This study was designed to determine the seroprevalence and risk factors for hepatitis C virus (HCV)) infection in veterans. Anti-HCV testing was performed in 1,032 patients and a questionnaire regarding sociodemographic characteristics and potential risk factors was administered. Adjusted prevalence of unique HCV-positive patients using outpatient services was 17.7% (95% confidence interval [CII 17.2%, 18.2%). The following risk factors were associated with HCV infection: a history of injection drug use (IDU), receipt of blood transfusion prior to 1992, history of tattoo (odds ratio [OR], 2.93; 95% CI, 1.70-5.08), combat job as a medical worker (OR, 2.68 95% CI, 1.25-5.60), history of incarceration over 48 hours (OR, 2.56 95% CI, 1.52-4.32), greater than 15 lifetime sexual partners (OR, 1.61; 95% CI, 0.94-2.76) and sexual relations with a prostitute (OR, 0.46 95% Cl, 0.25-0.82). We concluded that HCV is common in veterans. Risk factors independently associated with infection arc IDU, prior transfusion, prior tattoo, combat medical work, incarceration, and multiple opposite sex partners. Infection with HCV among veterans is strongly associated with traditional risk factors for infection and less strongly associated with combat-related risk.
引用
收藏
页码:1200 / 1205
页数:6
相关论文
共 19 条
[1]   The prevalence of hepatitis C virus infection in the United States, 1988 through 1994 [J].
Alter, MJ ;
Kruszon-Moran, D ;
Nainan, OV ;
McQuillan, GM ;
Gao, FX ;
Moyer, LA ;
Kaslow, RA ;
Margolis, HS .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (08) :556-562
[2]   RISK-FACTORS FOR ACUTE NON-A, NON-B HEPATITIS IN THE UNITED-STATES AND ASSOCIATION WITH HEPATITIS-C VIRUS-INFECTION [J].
ALTER, MJ ;
HADLER, SC ;
JUDSON, FN ;
MARES, A ;
ALEXANDER, WJ ;
HU, PY ;
MILLER, JK ;
MOYER, LA ;
FIELDS, HA ;
BRADLEY, DW ;
MARGOLIS, HS .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 264 (17) :2231-2235
[3]   COMMUNITY-ACQUIRED VIRAL HEPATITIS-B AND HEPATITIS-C IN THE UNITED-STATES [J].
ALTER, MJ .
GUT, 1993, 34 (02) :S17-S19
[4]  
ALTER MJ, 1997, HEPATOLOGY, V26, P625
[5]   Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection [J].
ConryCantilena, C ;
VanRaden, M ;
Gibble, J ;
Melpolder, J ;
Shakil, AO ;
Viladomiu, L ;
Cheung, L ;
DiBisceglie, A ;
Hoofnagle, J ;
Shih, JW ;
Kaslow, R ;
Ness, P ;
Alter, HJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (26) :1691-1696
[6]   Risk factors for acquisition of hepatitis C virus infection in blood donors: Results of a case-control study [J].
Delage, G ;
Infante-Rivard, C ;
Chiavetta, JA ;
Willems, B ;
Pi, D ;
Fast, M .
GASTROENTEROLOGY, 1999, 116 (04) :893-899
[7]   Prevalence of hepatitis C in prisons: WASH-C surveillance linked to self-reported risk behaviours [J].
Gore, SM ;
Bird, AG ;
Cameron, SO ;
Hutchinson, SJ ;
Burns, SM ;
Goldberg, DJ .
QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS, 1999, 92 (01) :25-32
[8]   PREVALENCE OF ANTIBODIES TO HEPATITIS-C VIRUS AND ASSOCIATION WITH INTRAVENOUS DRUG-ABUSE AND TATTOOING IN A NATIONAL PRISON IN NORWAY [J].
HOLSEN, DS ;
HARTHUG, S ;
MYRMEL, H .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1993, 12 (09) :673-676
[9]   Prevalence and incidence of hepatitis C virus infection in the US military: A seroepidemiologic survey of 21,000 troops [J].
Hyams, KC ;
Riddle, J ;
Rubertone, M ;
Trump, D ;
Alter, MJ ;
Cruess, DF ;
Han, XH ;
Nainam, OV ;
Seeff, LB ;
Mazzuchi, JF ;
Bailey, S .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2001, 153 (08) :764-770
[10]   TRANSMISSION OF HEPATITIS-C IN AN ISOLATED AREA IN JAPAN - COMMUNITY-ACQUIRED INFECTION [J].
KIYOSAWA, K ;
TANAKA, E ;
SODEYAMA, T ;
YOSHIZAWA, K ;
YABU, K ;
FURUTA, K ;
IMAI, H ;
NAKANO, Y ;
USUDA, S ;
UEMURA, K ;
FURUTA, S ;
WATANABE, Y ;
WATANABE, J ;
FUKUDA, Y ;
TAKAYAMA, T ;
URUSHIBARA, A ;
MATSUMOTO, A ;
MORI, H ;
KOBAYASHI, M ;
SUZUKI, T ;
YAMADA, S ;
SEKI, T ;
SHIMIZU, S ;
NAKAMURA, M ;
SONE, H ;
HARA, K ;
ICHIJO, T ;
OHIKE, Y ;
GIBO, Y ;
NAKATSUJI, Y ;
YODA, H ;
TSUCHIYA, K ;
HAYATA, T ;
IMAI, Y ;
KOBAYASHI, M ;
HARA, N .
GASTROENTEROLOGY, 1994, 106 (06) :1596-1602